REPLIGEN CORP (RGEN)

SEC filing

REPLIGEN CORP

RGEN · CIK 730272

4 · Aug 21, 2026 · Director, Chief Executive Officer Loeillot Olivier sold 5,426 shares at $180.00/share ($976.7K); exercised options for 10.85K shares

Director, Chief Executive Officer Loeillot Olivier sold 5,426 shares at $180.00/share ($976.7K); exercised options for 10.85K shares

Filed: Aug 21, 2026
Period: Aug 20, 2026
Accession: 0001628280-26-058417
Filer: REPLIGEN CORP

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1787342788.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1787342788.xml
Open SEC.gov